-+ 0.00%
-+ 0.00%
-+ 0.00%

IDEAYA BIOSCIENCES AND SERVIER ANNOUNCE DATA FROM THREE CLINICAL TRIALS AT ESMO 2026 SUPPORTING THE POTENTIAL OF DAROVASERTIB TO BECOME A FOUNDATIONAL NEW THERAPY FOR PATIENTS ACROSS THE TREATMENT JOURNEY OF UVEAL MELANOMA

Reuters·10/19/2026 10:00:02

Please log in to view news